|
Tetanusan 50%
|
-
|
V/NRP/09/0006
|
Kon-Pharma GmbH, Vācija
|
QB05XA30
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Calcium gluconate, Magnesium chloride hexahydrate, Disodium glycerophosphate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Kon-Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
08-Apr-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 26012021LI (26-Jan-2021)
|
| Labelling text: |
[DOCX] 26012021M (26-Jan-2021)
|
| Summary of product characteristics: |
[DOCX] 26012021ZA (26-Jan-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/09/0006-01 |
|
1 |
Polipropilēna flakons, 500 ml |
-
|
|
|
Tetanusan 24%
|
-
|
V/NRP/09/0005
|
Kon-Pharma GmbH, Vācija
|
QB05XA30
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Calcium gluconate, Magnesium chloride hexahydrate, Disodium glycerophosphate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bela-pharm GmbH&Co.KG, Vācija
|
| Date of authorisation/renewal: |
08-Apr-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 26012021LI (26-Jan-2021)
|
| Labelling text: |
[DOCX] 26012021M (26-Jan-2021)
|
| Summary of product characteristics: |
[DOCX] 26012021ZA (26-Jan-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/09/0005-01 |
|
1 |
Polipropilēna flakons, 500 ml |
-
|
|